Komori
Care Twentyone (2373) · InitiativeAdvanced

Aligning corporate value with shareholder value through restricted stock compensation

First written in FY2018. 9 of 17 entries say "Advanced", first in FY2019-Q1. Latest entry: FY2026-H1.

17entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019-Q1 – FY2023-Q2AdvancedFY2024-Q1 – FY2026-H12019: 420192020: 220202021: 220212022: 220222023: 320232024: 220242025: 120252026: 12026
Same theme, other companies
Medium- to Long-Term Incentives Through Equity Compensation Plans for Directors and EmployeesA theme 683 companies write about · 0 as a headwind · 706 as a tailwind

106 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.Comparing 200 of the theme's 706 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2026, the Company resolved to dispose of treasury shares to grant specified restricted stock to the Company's directors, and the payment procedure was completed on 16 March 2026.」

    For the disposal of 15,000 treasury shares as restricted stock to 3 directors, with a total disposal value of ¥6,780,000, the resolution was approved and the payment procedure was completed on 16 March 2026.
  2. FY2025-H1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 21 February 2025, the Company resolved to dispose of treasury shares to grant specified restricted stock to the Company's directors, and the payment procedure was completed on 17 March 2025.」

    For the disposal of 15,000 treasury shares as restricted stock to 4 directors, with a total disposal value of ¥5,805,000, the resolution was approved and the payment procedure was completed on 17 March.
  3. FY2024-Q2AchievedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2024, the Company resolved to dispose of treasury shares to grant specified restricted stock to the Company's directors, and the payment procedure was completed on 15 March 2024.」

    For the disposal of 15,000 restricted shares to 5 directors, approved on 20 February 2024, with a total disposal value of ¥9,675,000, the payment procedure was completed on 15 March.
  4. FY2024-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2024, the Company resolved to dispose of treasury shares to grant specified restricted stock to the Company's directors. Type and total number of shares to be disposed of: 15,000 common shares of the Company. Total disposal value: ¥9,675,000. Allottees: 5 directors, excluding outside directors, 15,000 shares.」

    For restricted stock compensation, a new allotment of 15,000 shares to 5 directors, with a total disposal value of ¥9.675 million, was approved, with 15 March 2024 set as the payment date.
  5. FY2023-Q3RestatedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2023, the Company resolved to dispose of treasury shares to grant specified restricted stock to the Company's directors, and the payment procedure was completed on 15 March 2023.」

    Regarding the disposal of 15,000 restricted shares to 3 directors, approved on 20 February 2023, with a total disposal value of ¥10,845,000, completion of payment continues to be disclosed.
  6. FY2023-Q2AchievedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2023, the Company resolved to dispose of treasury shares to grant specified restricted stock to the Company's directors, and the payment procedure was completed on 15 March 2023.」

    For the disposal of 15,000 restricted shares to 3 directors, approved on 20 February 2023, with a total disposal value of ¥10,845,000, the payment procedure was completed on 15 March.
  7. FY2023-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2023, the Company resolved to dispose of treasury shares to grant specified restricted stock to the Company's directors.」

    For restricted stock compensation, a new disposal of treasury shares was approved, with payment scheduled for 15 March 2023, involving 15,000 shares for 3 directors and a total disposal value of ¥10,845,000.
  8. FY2022-Q2AchievedAnnual report

    「Regarding the disposal of treasury shares as restricted stock resolved at a meeting of the Board of Directors held on 21 February 2022, the payment procedure was completed on 15 March 2022.」

    For the disposal of 15,000 restricted shares to 3 eligible directors, totaling ¥11,805,000, the payment procedure was completed on 15 March 2022.
  9. FY2022-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 21 February 2022, the Company resolved to grant monetary compensation claims totaling ¥11,805,000 to 3 eligible directors and allot them a total of 15,000 common shares as specified restricted stock, by having the eligible directors contribute all of those monetary compensation claims to the Company as property contributed in kind. The transfer restriction period has been set at 3 years, taking into consideration the need to provide the eligible directors with an incentive to sustainably increase the Company's corporate value and to promote value sharing between the eligible directors and shareholders.」

    For restricted stock compensation, a new allotment of 15,000 shares to 3 eligible directors, totaling ¥11,805,000, was approved, with a 3-year transfer restriction period.
  10. FY2021-Q3AchievedAnnual report

    「Regarding the disposal of treasury shares as restricted stock resolved at a meeting of the Board of Directors held on 22 February 2021, the payment procedure was completed on 15 March 2021.」

    For the disposal of 5,000 treasury shares as restricted stock for 3 directors, approved on 22 February 2021, totaling ¥11.7 million, the payment procedure was completed on 15 March 2021.
  11. FY2021-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 22 February 2021, the Company resolved to grant monetary compensation claims totaling ¥11,700,000 to 3 eligible directors and allot them a total of 5,000 common shares as specified restricted stock, by having the eligible directors contribute all of those monetary compensation claims to the Company as property contributed in kind. The transfer restriction period has been set at 3 years, taking into consideration the need to provide the eligible directors with an incentive to sustainably increase the Company's corporate value and to promote value sharing between the eligible directors and shareholders.」

    For restricted stock compensation, a new allotment of 5,000 shares to 3 eligible directors, totaling ¥11.7 million, was approved, with a 3-year transfer restriction period.
  12. FY2020-Q2AchievedAnnual report

    「Regarding the disposal of treasury shares as restricted stock resolved at a meeting of the Board of Directors held on 20 February 2020, the payment procedure was completed on 16 March 2020.」

    For the disposal of 5,000 treasury shares as restricted stock for directors, approved on 20 February 2020, totaling ¥7.58 million, the payment procedure was completed on 16 March 2020.
  13. FY2020-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2020, the Company resolved to grant monetary compensation claims totaling ¥7,580,000 to 3 eligible directors and allot them a total of 5,000 common shares as specified restricted stock, by having the eligible directors contribute all of those monetary compensation claims to the Company as property contributed in kind. The transfer restriction period has been set at 3 years, taking into consideration the need to provide the eligible directors with an incentive to sustainably increase the Company's corporate value and to promote value sharing between the eligible directors and shareholders.」

    For restricted stock compensation, a new allotment of 5,000 shares to 3 eligible directors, totaling ¥7.58 million, was approved, with a 3-year transfer restriction period.
  14. FY2019-Q3AchievedAnnual report

    「Regarding the disposal of treasury shares as restricted stock resolved at the meeting of the Board of Directors held on 20 February 2019, the payment procedures were completed on 15 March 2019 for the directors and on 14 June 2019 for the employees.」

    Payment procedures for the disposal of treasury shares as restricted stock compensation have been completed for 5,000 shares for directors and 45,400 shares for employees, completing the concrete implementation of the program.
  15. FY2019-Q2AdvancedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2019, the Company resolved to grant 4 eligible directors monetary compensation claims totaling ¥5,840,000 and allot a total of 5,000 common shares as restricted stock, with the eligible directors contributing the entirety of those monetary compensation claims as an in-kind contribution to the Company. The restriction period is 3 years, taking into consideration the aim of providing eligible directors with an incentive to achieve sustained growth in the Company’s corporate value and promoting value sharing between eligible directors and shareholders. The Company also resolved to allot a total of 49,100 common shares as restricted stock to 480 employees of the Company and its subsidiaries.」

    For restricted stock compensation, the company has disclosed specific implementation details, including the payment date, for the disposal of 5,000 shares to 4 directors and 49,100 shares to 480 employees of the Company and its subsidiaries.
  16. FY2019-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 20 February 2019, the Company resolved to grant 4 eligible directors monetary compensation claims totaling ¥5,840,000 and allot a total of 5,000 common shares as restricted stock, with the eligible directors contributing the entirety of those monetary compensation claims as an in-kind contribution to the Company. The restriction period is 3 years, taking into consideration the aim of providing eligible directors with an incentive to achieve sustained growth in the Company’s corporate value and promoting value sharing between eligible directors and shareholders. The Company also resolved to allot a total of 49,100 common shares as restricted stock to 480 employees of the Company and its subsidiaries.」

    The restricted stock compensation plan has been specified in detail, including the resolution to allot 5,000 shares to 4 directors and the resolution to allot 49,100 shares to 480 employees of the Company and its subsidiaries.
  17. FY2018First statedAnnual report

    「The purpose is to further link compensation for eligible directors to share value, provide them with incentives to sustainably increase corporate value and promote greater value sharing between eligible directors and shareholders.」

    Describes the policy of introducing a specified restricted-stock compensation plan approved at the January 2019 shareholders’ meeting to link executive compensation with share value and promote value sharing with shareholders.
Moved together

"Improving profitability in facility-based care through new openings and rapid occupancy" moved the same way as this thread, in the same document, in 15 of its 17 moves.

1514131288★123456
  1. ★This thread
  2. 1Improving profitability in facility-based care through new openings and rapid occupancy15×
  3. 2New openings and early profitability in home-based care supported by marketing and personnel development14×
  4. 3Expanding adjacent businesses, including support for children with disabilities, childcare, welfare equipment and home nursing13×
  5. 4Increase in lease assets and lease liabilities accompanying new openings12×
  6. 5Deteriorating profitability in facility-based care due to delayed recovery of investment in new facilities8×
  7. 6Expanding the overall care business through active development of home-based, facility-based and adjacent services8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Care Twentyone yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.